Industry:Biotech & Pharma
Abraxis BioScience Inc
Abraxis BioScience Inc (ABII:US)
was acquired by CELG:US
Abraxis BioScience, Inc. operates as a fully integrated biotechnology company. The Company develops a full spectrum of products used primarily in oncology, infectious diseases and critical care, including a protein-based nanoparticle chemotherapeutic compound for the treatment of breast cancer.